Clinical Trial

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To main objective is to evaluate the safety, tolerability, and pharmacokinetic profile of single or multiple oral doses of ABSK061 mini-tablets and to evaluate the effect of soft food with ABSK061 mini-tablets on its pharmacokinetic profile in healthy adult participants
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-03.
Status change: Recruiting → Completed 2026-06-25
Trial Details
NCT Number NCT07007546
Lead Sponsor Abbisko Therapeutics Co, Ltd
Conditions Healthy
Enrollment 42 participants
Start Date 2025-05-17
Primary Completion 2025-07-30 (estimated)
Study Completion 2026-04-14 (estimated)
Updated on ClinicalTrials.gov 2026-06-29